GT Biopharma's total assets for Q3 2025 were $4.32M, a decrease of ― from the previous quarter. GTBP total liabilities were $1.32M for the fiscal quarter, a ― a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.